A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy

NCT03838133 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Hallux Valgus

Interventions

DRUG: TLC590
DRUG: Naropin®
DRUG: Normal Saline
DRUG: Bupivacaine

Sponsor

Taiwan Liposome Company